The adaptor Act1 is required for interleukin 17–dependent signaling associated with autoimmune and inflammatory disease

[1]  A. Sher,et al.  IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.

[2]  H. Kubo,et al.  IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. , 2006, Biochemical and Biophysical Research Communications - BBRC.

[3]  Zihua Hu,et al.  Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.

[4]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[5]  J. Derry,et al.  Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex , 2006, The Journal of Immunology.

[6]  B. Becher,et al.  Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain , 2006, Journal of Molecular Medicine.

[7]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[8]  L. Presta,et al.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. , 2006, The Journal of clinical investigation.

[9]  J. Kolls,et al.  Critical role of IL‐17 receptor signaling in acute TNBS‐induced colitis , 2006, Inflammatory bowel diseases.

[10]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[11]  Y. Iwakura,et al.  The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.

[12]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[13]  F. Ruemmele,et al.  Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth. , 2005, Biochemical and biophysical research communications.

[14]  Ki-Young Lee,et al.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.

[15]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[16]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[17]  L. Joosten,et al.  Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. , 2005, Arthritis and rheumatism.

[18]  S. Shapiro,et al.  An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  S. Akira,et al.  Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.

[20]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[21]  E. C. Snow,et al.  Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. , 2004, Immunity.

[22]  Sarah L. Gaffen,et al.  Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members* , 2004, Journal of Biological Chemistry.

[23]  Zhendong Zhao,et al.  IFN Regulatory Factor-1 Is Required for the Up-Regulation of the CD40-NF-κB Activator 1 Axis During Airway Inflammation1 , 2003, The Journal of Immunology.

[24]  Y. Ho,et al.  Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.

[25]  Frank Eisenhaber,et al.  The STIR-domain superfamily in signal transduction, development and immunity. , 2003, Trends in biochemical sciences.

[26]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[27]  P. Chambon,et al.  Expression of conditional cre recombinase in epithelial tissues of transgenic mice , 2003, Genesis.

[28]  I. Homma,et al.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. , 2002, Immunity.

[29]  W. Sha,et al.  Constitutive Expression of the B7h Ligand for Inducible Costimulator on Naive B Cells Is Extinguished after Activation by Distinct B Cell Receptor and Interleukin 4 Receptor–mediated Pathways and Can Be Rescued by CD40 Signaling , 2002, The Journal of experimental medicine.

[30]  Zhengfan Jiang,et al.  Role of NFκB activator Act1 in CD40-mediated signaling in epithelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Benveniste,et al.  Immune function of astrocytes , 2001, Glia.

[32]  V. Trajković,et al.  Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes , 2001, Journal of Neuroimmunology.

[33]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[34]  A. Leonardi,et al.  CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  X. Hua,et al.  Act1, an NF-κB-activating protein , 2000 .

[36]  A. Israël,et al.  Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. , 2000, Genes & development.

[37]  K. Yamaguchi,et al.  Requirement of Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 in Interleukin 17 Signal Transduction , 2000, The Journal of experimental medicine.

[38]  R. Ransohoff,et al.  TGFβ1 selectively up‐regulates CCR1 expression in primary murine astrocytes , 2000, Glia.

[39]  H. Reinecker,et al.  NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. , 1999, Journal of immunology.

[40]  S. Morony,et al.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.

[41]  J. Fjell,et al.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. , 1998, Journal of immunology.

[42]  P. Heinrich,et al.  Oncostatin M and the Interleukin-6 and Soluble Interleukin-6 Receptor Complex Regulate α1-Antichymotrypsin Expression in Human Cortical Astrocytes* , 1998, The Journal of Biological Chemistry.

[43]  J. Derry,et al.  Molecular characterization of the human interleukin (IL)-17 receptor. , 1997, Cytokine.

[44]  R. J. Hocking,et al.  TGFb in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells , 2022 .